BGI Genomics Co Ltd
SZSE:300676
BGI Genomics Co Ltd
Operating Expenses
BGI Genomics Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BGI Genomics Co Ltd
SZSE:300676
|
Operating Expenses
-¥2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Expenses
-¥23.5B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Expenses
-¥6.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Expenses
-¥3.1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Expenses
-¥4.8B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-30%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Expenses
-¥458.8m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is BGI Genomics Co Ltd's Operating Expenses?
Operating Expenses
-2B
CNY
Based on the financial report for Mar 31, 2024, BGI Genomics Co Ltd's Operating Expenses amounts to -2B CNY.
What is BGI Genomics Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-14%
Over the last year, the Operating Expenses growth was 32%. The average annual Operating Expenses growth rates for BGI Genomics Co Ltd have been 8% over the past three years , -14% over the past five years .